Baylor College of Medicine has secured nearly $10 million from the NIH BRAIN Initiative to explore treatments for the depressive phase of bipolar disorder. Over five years, researchers will evaluate the efficacy and safety of deep brain stimulation (DBS) in patients with bipolar depression unresponsive to existing therapies. The study also aims to identify mood state biomarkers through brain recordings.
